MINORITY HOLDER STOCK PURCHASE AGREEMENTMinority Holder Stock Purchase Agreement • October 3rd, 2019 • OncoCyte Corp • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledOctober 3rd, 2019 Company Industry JurisdictionTHIS MINORITY HOLDER STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of September [●], 2019, by and between (i) OncoCyte Corporation, a California corporation (“Buyer”), and (ii) the individual named as the Minority Holder on the signature page hereto (the “Minority Holder”). Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the SSPA (as defined below).